Logo

MWG Says It Successfully Opposed Applera Nucleic Acid Amplification Patent

Mar 18, 2004

NEW YORK, March 18 - (GenomeWeb News) - MWG Biotech said today that it was successful in opposing a European patent held by Applera over a patent for nucleic acid amplification.

 

The company, based in Ebersberg, Germany, said the European Patent Office revoked Applera's European Patent No. 236 069 B1, entitled "Apparatus and method for performing automated amplification of nucleic acid sequences and assays using heating and cooling steps," after MWG and others had opposed the patent.

 

This decision, the company said, is final. "There are no further judicial remedies," MWG said in a statement.

 

Applera had not issued any public statement on this matter.

 

Breaking News
The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.